Publications

Export 94 results:
Sort by: [ Author  (Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
A.J.El-Khodary, Sh.Omar, N. M. Ali, I. A. Mourad, M.M.Saber, S. Ismail, M. Barsoom, and I. A. Osman, "Neoadjuvant chemotherapy in operable breast cancer", J. Egypt. Nat. Cancer Inst,, vol. 6, issue 2, pp. 233-237, 1993.
AA, Z., R. H, E. G. MM, S. MM, E. D, and S. MA, "Gastric carcinoma at Tanta Cancer Center: a comparative retrospective clinico-pathological study of the elderly versus the non-elderly.", Journal of the Egyptian National Cancer Institute , vol. 26, issue 3, pp. 127-37., 2014.
Abdallah, S. K. M., Significance of additional chromosomal abnormalities in Egyptian chronic myeloid leukemia patients, , Cairo, National Cancer Institute- Cairo University, 2019.
Abdelaziz, A. A., Treatment outcomes of Germ Cell Tumors at the National Cancer Institute, Cairo University, , Cairo, National Cancer Institute- Cairo University, 2012.
Abdelhameed, A. S., Dysregulation of Micr RNA in adult acute myeloid leukemia, , Cairo, National Cancer Institute- Cairo University, 2016.
Akel, S., M.M.Saber, H. Abdallah, I. el-Attar, and M. Zaghloul, "The combination of various tumor markers in carcinoma of the breast: evaluation and clinical significance", J. Egypt. Nat. Cancer Inst. , vol. 6, issue 2, pp. 425-435, 1993.
Albana, I. S. K., Prognostic factors in breast cancer patients with brain metastasis', , Cairo, National Cancer Institute- Cairo University, 2009.
Atef, H., M. Mansour, and M. A. Saber, "- Anemia in cancer patients: The role of treatment with Erythropoetin alpha on patients receiving chemotherapy. ", Med. J. Cairo Univ., vol. 68, issue 4 (suppl. 11) , pp. 1-8, 2000.
B
Bahnassy, A. A., M. M. Saber, M. G. Mahmoud, M. S. Abdel-Lateif, M. A. Samra, R. A. M. Elfatah, A. - R. N. Zekri, and S. E. Salem, "o The role of circulating tumor cells in metastatic breast cancer: prognostic and predictive value. ", Molecular Biology Reports, vol. 45, pp. 151–158, 2018.
E
El-Daly., U. M. A., Relation between Adipocytokines and HCV related hepatocellular carcinoma., , 2017, National Cancer Institute- Cairo University, 2017.
El-Ela., R. Y. A., Treatment outcomes of Targeted Therapy in CML patients at the National Cancer Institute in the last 5 years. , , Cairo, National Cancer Institute- Cairo University, 2013.
El-Helw, L. M. A., MDR expression in relapsed or resistant Hodgkin's disease in relation to other prognostic factors, , Cairo, National Cancer Institute- Cairo University, 1994.
El-Mahallawy, H., M. M. Saber, I. El-Attar, and A. Z. Z. A. M.KAMEL, "Serum IL-2R as an indicator of residual disease in patients with malignant lymphomas", ESMO Conference, Vienna, 1-5 Nov. 1996.
El-Mahallawy, H. A., R. A. M. Hamid, S. S. Hassan, S. Radwan, and M. A. Saber, "The Increased Frequency of Carbapenem Resistant Non Fermenting Gram Negative Pathogens as Causes of Health Care Associated Infections in Adult Cancer Patients", Journal of Cancer Therapy,, vol. 6, pp. 881-888, 2015.
El-Mawla, N. M. G., A. S. Ibrahim, S. EL-Said, A. A.Zaki, M. M.Saber, A.I.El-Khodary, Hussein.M.Khalid, M. G. Rabab, H. M.El-Zawahri, Abdel-Wareth, et al., "Hodgkin's disease: A clinico-epidemiological study of 587 cases", J. Egypt. Nat, Cancer Inst., vol. 5, issue 2, pp. 393-399,, 1991.
El-Mously, R. H. I., The significance of vitamine D level in Egyptian patients with breast cancer. , , Cairo, Alazhar University, 2012.
El-Rahiem, R. A. A., R. M. Mohareb, M. M. Saber, and M. E. El-Houseini., "Serum amino acids profiling is a novel biomarker for enhanced detection of breast and liver cancer. ", Asian Academic Research Journal of Multidisciplinary, vol. 3, issue 11, pp. 2319-2801., 2016.
Elgohary, N. A., Genetic Mutations Associated With Hepatocellular Carcinoma Development, , Cairo, National Cancer Institute- Cairo University, 2016.
Elgohary, N., R. Pellegrino, O. Neumann, H. M. Elzawahry, M. M. Saber, A. A. Zeeneldin, and R. Geff, "Protumorigenic role of Timeless in hepatocellular carcinoma", INTERNATIONAL JOURNAL OF ONCOLOGY, vol. 46, issue 2, pp. 597-606., 2015.
Elhelw, L. M. A., MDR expression in relapsed or resistant Hodgkin's disease in relation to other prognostic factors, , Cairo, National Cancer Institute- Cairo University, 1995.
Elzawahry, H. M., M. M. Saber, N. M. Mokhtar, A. A. Zeeneldin, Y. M. Ismail, and N. H. Alieldin, "Role of p53 in predicting resistance to adjuvant tamoxifen in hormone-receptor positive postmenopausal breast cancer patients. ", Journal of the Egyptian National Cancer Institute , vol. 25, issue 4, pp. 181-191, 2013.